A. Richard Miskoff, DO, PA — Edison, New Jersey

A. Richard Miskoff, DO, PA is a clinical research site located in Edison, New Jersey, United States 08818.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

A. Richard Miskoff, DO, PA has participated in 1 clinical trials.

Therapeutic areas: Ovarian Neoplasms.

Sponsors: Telik.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Edison

Browse all research sites in New Jersey · View every site in Edison

• Hackensack Meridian Neuroscience Institute at JFK University Medical Center
• JFK Neuroscience Institute, HMH JFK University Medical Center
• Hackensack University Medical Center
• JFK university
• Jersey Shore University Medical Center
• JFK University Medical Center
• The Community Hospital Group Inc. t/a JFK Medical Center
• JFK Neuroscience Institute, JFK University Medical Center
• John F Kennedy Medical Center
• JFK Medical Center
• GSK Investigational Site
• NJ Retina

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for A. Richard Miskoff, DO, PA?

A. Richard Miskoff, DO, PA has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has A. Richard Miskoff, DO, PA conducted?

A. Richard Miskoff, DO, PA has 1 clinical trials on record. Their work covers Ovarian Neoplasms.

Is A. Richard Miskoff, DO, PA accredited by Crixeo Clinical Trials?

A. Richard Miskoff, DO, PA has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about A. Richard Miskoff, DO, PA?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.